NCT02479737View on ClinicalTrials.gov

Active Clearance Technology (ACT) II German Multicenter Trial

UnknownOBSERVATIONAL
Enrollment

1,113

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

July 31, 2017

Study Completion Date

December 31, 2017

Conditions
Heart Surgery
Interventions
DEVICE

Blood drainage post cardiac surgery using PleuraFlow System

Trial Locations (2)

90471

RECRUITING

Paracelsus Medical University, Klinikum, Nuremberg, Germany, Nuremberg

97616

RECRUITING

Herz- und Gefäßklinik GmbH, Bad Neustadt an der Saale

Sponsors

Collaborators (1)

ClearFlow, Inc.
All Listed Sponsors
collaborator

ClearFlow, Inc.

INDUSTRY

lead

Prof. Dr. Theodor Fischlein

OTHER

NCT02479737 - Active Clearance Technology (ACT) II German Multicenter Trial | Biotech Hunter | Biotech Hunter